AEON Biopharma (AEON) Other Non-Current Assets (2021 - 2026)
AEON Biopharma (AEON) posted Other Non-Current Assets of $948000.0 for Q4 2025, up 3168.97% sequentially from $29000.0 in Q3 2025, and up 3168.97% YoY from $29000.0 in Q4 2024.
AEON Biopharma (AEON) Other Non-Current Assets (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Other Non-Current Assets for 5 years, with the latest figure at $948000.0 in Q4 2025.
- Quarterly Other Non-Current Assets rose 3168.97% year-over-year to $948000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $948000.0 (up 3168.97% YoY) and the FY2025 annual result came in at $948000.0, up 3168.97% from the prior year.
- Other Non-Current Assets grew to $948000.0 in Q4 2025 per AEON's latest filing, from $29000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $948000.0 in Q4 2025 and troughed at $29000.0 in Q3 2023.
- A 5-year average of $113703.9 and a median of $29000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets slipped 14.71% in 2023, then surged 3168.97% in 2025.
- Over 5 years, Other Non-Current Assets stood at $34619.0 in 2021, then dropped by 1.79% to $34000.0 in 2022, then retreated by 14.71% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then soared by 3168.97% to $948000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $948000.0, $29000.0, and $29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 62.96 Mn |
| 10 | AEON Biopharma | 9.37 Mn | 5.94 Mn | - | 863,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 863,000.00 |
| Dec 31, 2025 | 948,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 34,619.00 |
| Sep 30, 2021 | 116,285.00 |
| Jun 30, 2021 | 197,951.00 |